Cost‐Utility Analysis of Low‐Dose Pioglitazone in a Population With Prediabetes and a History of Stroke or Transient Ischemic Attack

Background Pioglitazone significantly reduces the risk of stroke in people with diabetes, and in those with prediabetes, it markedly reduces the risk of stroke/myocardial infarction and new‐onset diabetes. Low‐dose pioglitazone provides most of the clinical benefits of high‐dose pioglitazone, with f...

Full description

Saved in:
Bibliographic Details
Main Authors: Fei Yuan, J. David Spence, Jean‐Eric Tarride
Format: Article
Language:English
Published: Wiley 2024-11-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.034531
Tags: Add Tag
No Tags, Be the first to tag this record!